Stay updated on Pembrolizumab SBRT in TKI mRCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab SBRT in TKI mRCC Clinical Trial page.

Latest updates to the Pembrolizumab SBRT in TKI mRCC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page's revision label was updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision label on the page updated from v3.2.0 to v3.3.1; no other visible content changes.SummaryDifference0.1%

- Check29 days agoChange DetectedThe page no longer displays the government funding status notice that previously appeared at the top. All study details, eligibility criteria, and contact information remain unchanged.SummaryDifference0.4%

- Check43 days agoChange DetectedThe new screenshot shows only minor visual/layout adjustments with no changes to core study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedSummary: The page now displays a funding-status notice impacting operations and announces a new software version v3.2.0, replacing v3.1.0.SummaryDifference3%

- Check79 days agoChange DetectedCore page content updated to a new version (v3.1.0) from v3.0.2. No other substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab SBRT in TKI mRCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab SBRT in TKI mRCC Clinical Trial page.